HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Non-Current Debt of $72.1 million for Q2 2026, up 6.28% year-over-year from $67.8 million in Q2 2025, and up 5.74% quarter-over-quarter from $68.2 million in Q4 2025.
HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Non-Current Debt for 12 consecutive years, with $72.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Debt rose 6.28% year-over-year to $72.1 million; the TTM figure through Jun 2026 stood at $72.1 million (up 6.28% YoY), while the FY2025 annual figure was $68.2 million, changed N/A from the prior year.
- Non-Current Debt rose to $72.1 million in Q2 2026 per HCM's latest filing, from $68.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $72.1 million in Q2 2026 and bottomed at $418000.0 in Q2 2022.
- Historically, Non-Current Debt has averaged $46.1 million across 5 years, with a median of $55.6 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Debt soared 9504.55% — and 2026, when it climbed 6.28%.
- HUTCHMED (China)'s Non-Current Debt stood at $18.1 million in 2022, then surged by 121.76% to $40.1 million in 2023, then jumped by 38.57% to $55.6 million in 2024, then advanced by 22.57% to $68.2 million in 2025, then gained by 5.74% to $72.1 million in 2026.
- Business Quant data shows HCM's Non-Current Debt at $72.1 million in Q2 2026, $68.2 million in Q4 2025, and $67.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 72.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.10 Mn |
| Dec 31, 2025 | 68.19 Mn |
| Jun 30, 2025 | 67.84 Mn |
| Jun 30, 2024 | 55.63 Mn |
| Jun 30, 2023 | 40.15 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Jun 30, 2022 | 418,000.00 |
| Mar 31, 2021 | 26.87 Mn |
| Jun 30, 2020 | 26.84 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 26.74 Mn |
| Jun 30, 2018 | 26.69 Mn |
| Jun 30, 2017 | 19.99 Mn |
| Dec 31, 2016 | 26.83 Mn |
| Jun 30, 2016 | 26.80 Mn |
| Dec 31, 2015 | 26.77 Mn |